Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer

Clinical trial NCT02499835 · COMPLETED

Trial details

NCT number: NCT02499835
Sponsor: University of Wisconsin, Madison
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hormone-Resistant Prostate Cancer Metastatic Malignant Neoplasm in the Bone Metastatic Malignant Neoplasm in the Soft Tissues Metastatic Prostate Carcinoma Prostate Adenocarcinoma Recurrent Prostate Carcinoma Stage IV Prostate Cancer

Start date: 2015-07-01
Primary completion: 2021-08-09
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.